123 related articles for article (PubMed ID: 2352144)
1. Preliminary evaluation of the correlation between in vitro release and in vivo bioavailability of two aminophylline slow-release tablets.
Lin SY; Kao YH; Chang HN
J Pharm Sci; 1990 Apr; 79(4):326-30. PubMed ID: 2352144
[TBL] [Abstract][Full Text] [Related]
2. An in-vitro comparison of controlled release aminophylline tablets: Phyllocontin Continus and Pecram.
Smart JD; Barnes MS; Norris MJ
J Pharm Pharmacol; 1992 Jul; 44(7):623-5. PubMed ID: 1357150
[TBL] [Abstract][Full Text] [Related]
3. Biopharmaceutical characterization of oral theophylline and aminophylline tablets. Quantitative correlation between dissolution and bioavailability studies.
Varshosaz J; Ghafghazi T; Raisi A; Falamarzian M
Eur J Pharm Biopharm; 2000 Sep; 50(2):301-6. PubMed ID: 10962242
[TBL] [Abstract][Full Text] [Related]
4. [Studies on drug release from aminophylline konjac glucomannan matrix tablet].
Zhu GQ; Zhang Y; Liu JH
Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(21):2236-9. PubMed ID: 18309662
[TBL] [Abstract][Full Text] [Related]
5. [Preparation and evaluation of press-coated aminophylline tablet using crystalline cellulose and polyethylene glycol in the outer shell for timed-release dosage forms].
Watanabe Y; Mukai B; Kawamura K; Ishikawa T; Namiki M; Utoguchi N; Fujii M
Yakugaku Zasshi; 2002 Feb; 122(2):157-62. PubMed ID: 11857956
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
Gupta S; Raina RK; Samotra K; Gupta KL
Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic disposition of an immediate-release aminophylline and a sustained-release theophylline formulation in the horse.
Goetz TE; Munsiff IJ; McKiernan BC
J Vet Pharmacol Ther; 1989 Dec; 12(4):369-77. PubMed ID: 2614856
[TBL] [Abstract][Full Text] [Related]
8. Dissolution of theophylline from film-coated slow release mini-tablets in various dissolution media.
Fassihi AR; Munday DL
J Pharm Pharmacol; 1989 Jun; 41(6):369-72. PubMed ID: 2570830
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
Lu Z; Fassihi R
AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary study on the pharmacokinetics of aminophylline controlled-release tablets].
Lin YG
Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):1-3, 61. PubMed ID: 3197163
[No Abstract] [Full Text] [Related]
11. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
12. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics of theophylline and ethylenediamine following single and repeated doses of a sustained-release aminophylline preparation to volunteers.
Cotgreave IA; Caldwell J
J Pharm Pharmacol; 1985 Sep; 37(9):618-21. PubMed ID: 2867181
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of 1-deoxynojirimycin sustained-release pellets vs conventional immediate-release tablets.
Sun Z; Yuan S; Zhao H; Wang Z; Liu Z
J Microencapsul; 2017 May; 34(3):293-298. PubMed ID: 28425304
[TBL] [Abstract][Full Text] [Related]
15. In-vitro dissolution behavior of some sustained-release theophylline dosage forms.
Lin SY; Yang JC
Pharm Acta Helv; 1989; 64(8):236-40. PubMed ID: 2780758
[TBL] [Abstract][Full Text] [Related]
16. Theophylline versus aminophylline in rectal administration.
Touitou E; Yosselson-Superstine S
J Clin Hosp Pharm; 1985 Jun; 10(2):211-7. PubMed ID: 4019794
[TBL] [Abstract][Full Text] [Related]
17. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
18. [Bioavailability of a delayed-action aminophylline preparation].
Regazzi MB; Guarnone E; Bartoli A; Ciardelli L; Piacentini P
Minerva Med; 1985 Mar; 76(13):641-5. PubMed ID: 3991030
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of terbutaline given in slow-release tablets.
Nyberg L; Kennedy BM
Eur J Respir Dis Suppl; 1984; 134():119-39. PubMed ID: 6586473
[TBL] [Abstract][Full Text] [Related]
20. In-vitro and in-vivo correlation for two gliclazide extended-release tablets.
Mandal U; Ray KK; Gowda V; Ghosh A; Pal TK
J Pharm Pharmacol; 2007 Jul; 59(7):971-6. PubMed ID: 17637192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
